NO913649D0 - Kontrollert frigjoerings-leveringsanordning for makromolekylaere proteiner. - Google Patents

Kontrollert frigjoerings-leveringsanordning for makromolekylaere proteiner.

Info

Publication number
NO913649D0
NO913649D0 NO913649A NO913649A NO913649D0 NO 913649 D0 NO913649 D0 NO 913649D0 NO 913649 A NO913649 A NO 913649A NO 913649 A NO913649 A NO 913649A NO 913649 D0 NO913649 D0 NO 913649D0
Authority
NO
Norway
Prior art keywords
delivery
beadlets
macromolecular
macromolecular proteins
animal
Prior art date
Application number
NO913649A
Other languages
English (en)
Norwegian (no)
Other versions
NO913649L (no
Inventor
K N Sivaramakrishnan
Lindy F Miller
Original Assignee
Pitman Moore Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pitman Moore Inc filed Critical Pitman Moore Inc
Publication of NO913649L publication Critical patent/NO913649L/no
Publication of NO913649D0 publication Critical patent/NO913649D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO913649A 1989-03-17 1991-09-16 Kontrollert frigjoerings-leveringsanordning for makromolekylaere proteiner. NO913649D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32474089A 1989-03-17 1989-03-17
PCT/US1990/001340 WO1990011070A1 (en) 1989-03-17 1990-03-13 Controlled release delivery device for macromolecular proteins

Publications (2)

Publication Number Publication Date
NO913649L NO913649L (no) 1991-09-16
NO913649D0 true NO913649D0 (no) 1991-09-16

Family

ID=23264894

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913649A NO913649D0 (no) 1989-03-17 1991-09-16 Kontrollert frigjoerings-leveringsanordning for makromolekylaere proteiner.

Country Status (9)

Country Link
EP (1) EP0463061B1 (de)
JP (1) JPH04504122A (de)
AT (1) ATE90203T1 (de)
AU (1) AU634529B2 (de)
DE (1) DE69001898T2 (de)
DK (1) DK0463061T3 (de)
ES (1) ES2042292T3 (de)
NO (1) NO913649D0 (de)
WO (1) WO1990011070A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ242065A (en) * 1991-03-26 1996-06-25 Csl Ltd Delayed release implant having a degradable or rupturable polymeric coating
US6613332B1 (en) 1991-06-21 2003-09-02 The University Of Cincinnati Oral administration of therapeutic proteins
EP0590060B1 (de) * 1991-06-21 1997-09-17 University Of Cincinnati Oral verabreichbare therapeutische proteine und herstellungsverfahren
WO1993013792A1 (en) * 1992-01-13 1993-07-22 Pitman-Moore, Inc. Delayed release device for transition metal/protein complexes
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
SG52402A1 (en) * 1992-12-22 1998-09-28 Univ Cincinnati Oral administration of immunologically active biomolecules and other therapeutic proteins
KR100260632B1 (ko) * 1992-12-28 2000-07-01 성재갑 이식형 소마토트로핀 조성물
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
WO2002000212A1 (en) * 2000-06-28 2002-01-03 Nitrosystems, Inc. Controlled release arginine formulations
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
GB9808052D0 (en) 1998-04-17 1998-06-17 Secr Defence Implants for administering substances and methods of producing implants
DE19820529A1 (de) * 1998-05-08 1999-11-11 Lohmann Therapie Syst Lts Wirkstoff enthaltende orale und mucosale Zubereitung mit steuerbarer Wirkstofffreisetzung und ihre Verwendung
EP1064934A1 (de) 1999-06-30 2001-01-03 Applied Research Systems ARS Holding N.V. Gefriergetrocknete GRF-enthaltende Arzneimittel
CZ2002336A3 (cs) * 1999-07-30 2002-06-12 Smithkline Beecham Plc Multikomponentní farmaceutická dávková forma
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
US20030050620A1 (en) * 2001-09-07 2003-03-13 Isa Odidi Combinatorial type controlled release drug delivery device
EP2112920B1 (de) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Protonenpumpeninhibitoren enthaltende kapseln, die verschieden aufgebaute untereinheiten zur verzögerten wirkstofffreisetzung enthalten
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8173148B2 (en) * 2004-11-10 2012-05-08 Tolmar Therapeutics, Inc. Stabilized polymeric delivery system comprising a water-insoluble polymer and an organic liquid
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
EP2231120B1 (de) * 2007-12-21 2011-06-29 Merck Patent GmbH Feststofflipid-mikrokapseln mit einem wachstumshormon im inneren festkern
EP2427179A4 (de) 2009-05-04 2013-09-11 Psivida Inc Poröse partikel zur freisetzung von silicium-arzneimitteln
EP2635255B1 (de) 2010-11-01 2019-08-21 EyePoint Pharmaceuticals US, Inc. Biologisch abbaubare vorrichtungen auf siliciumbasis zur abgabe therapeutischer mittel
JP2016512839A (ja) 2013-03-15 2016-05-09 シヴィダ・ユーエス・インコーポレイテッドＰｓｉｖｉｄａ Ｕｓ， Ｉｎｃ． 治療物質の送達のための生体内分解性ケイ素系組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2738303A (en) * 1952-07-18 1956-03-13 Smith Kline French Lab Sympathomimetic preparation
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
WO1988001506A1 (en) * 1986-08-28 1988-03-10 Thomas Ko Sai Ying Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals
DE3777658D1 (de) * 1986-08-28 1992-04-23 Enzacor Pty Ltd Tierwachstumserreger.
JP2792862B2 (ja) * 1988-07-30 1998-09-03 寛治 高田 経口腸溶製剤

Also Published As

Publication number Publication date
NO913649L (no) 1991-09-16
AU5279290A (en) 1990-10-22
ES2042292T3 (es) 1993-12-01
AU634529B2 (en) 1993-02-25
ATE90203T1 (de) 1993-06-15
EP0463061A1 (de) 1992-01-02
DE69001898T2 (de) 1993-09-23
EP0463061B1 (de) 1993-06-09
JPH04504122A (ja) 1992-07-23
WO1990011070A1 (en) 1990-10-04
DE69001898D1 (de) 1993-07-15
DK0463061T3 (da) 1993-07-12

Similar Documents

Publication Publication Date Title
NO913649D0 (no) Kontrollert frigjoerings-leveringsanordning for makromolekylaere proteiner.
KR900009106A (ko) 체계속으로의 유체의 잠입을 조절하는 수단을 포함하는 전달시스템
ES2172239T3 (es) Sistema osmotico de liberacion de farmacos.
ES2157975T3 (es) Soluciones farmaceuticas con solubilidad mejorada.
DE69521994D1 (de) Zusammensetzungen welche dna zerstoerende agentien und p53 enthalten
ES2037082T3 (es) Una composicion para la liberacion controlada de un farmaco.
DE60001835T2 (de) Mesalazine enthaltende pharmazeutische zusammensetzungen mit gesteuerte freisetzung
IE871584L (en) Sustained release capsule.
GR3026721T3 (en) Preparation for controlled release of drugs for ruminants
BR8403569A (pt) Conjunto de acao retardada para liberacao de uma unidade de ingrediente ativo e unidade de dosagem de ingrediente ativo
WO2002069848A3 (en) Apparatus for stent deployment with delivery of bioactive agents
FR2655266B1 (fr) Compositions pharmaceutiques a base de cimetidine.
DE68909772D1 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
IT8820073A0 (it) Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
ES2022454B3 (es) Sistema terapeutico para la liberacion controlada de drogas.
HUP0003840A2 (hu) Szabályozott hatóanyagleadású gyógyászati készítmények
CO4970832A1 (es) Nuevas formulaciones y procesos para su fabricacion
GR3032224T3 (en) Therapeutic agent for threatened abortion.
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
GB1537047A (en) Eye ointment
DE69012742D1 (de) Azolderivate und fungizide Medikamente, diese als wirkende Komponente enthaltend.
DE69725155D1 (de) Pharmazeutische zubereitungen enthaltend eine kombination aus isosorbid-nitrat und acetylsalicylsaeure
DE3688355D1 (de) Fester koerper mit ueberzogenem kern.
MX9203154A (es) Sistema terapeutico de liberacion regulada para formulaciones farmaceuticas liquidas.
RU94016574A (ru) Препарат для лечения и профилактики мастита крупного рогатого скота в сухостойный период